Sorensen Endowed Prof. Chen X. Chen’s Team Awarded $2M NIH R01 Grant to Study Vaginal Microbiome and Dysmenorrhea

Dr. Chen X. Chen’s team has been awarded over $2 million by the National Institutes of Health (NIH) to fund a 5-year study on the role of the vaginal microbiome in dysmenorrhea. In this innovative project, Dr. Chen is leading an interdisciplinary team of clinician scientists, basic scientists, and experts in bioinformatics and machine learning. […]
Dr. Najafi Appointed to Federal Advisory Committee

Bijan Najafi, Ph.D., MSc, Director of the Center to Stream Healthcare in Place (C2SHIP) for Baylor College of Medicine and Professor of Surgery and Director of the Digital Health and Access Center (DiHAC), has been appointed as a Federal Advisory Committee member on the Rehabilitation Research and Development Service Scientific Merit Review Board Subcommittee on […]
NeuroMetrix Reports Encouraging Results from Pilot Clinical Trial of Quell® in Post-Acute COVID-19 Syndrome (Long COVID)

NeuroMetrix, Inc. (Nasdaq: NURO) reported the recent presentation of data from a clinical trial of Quell wearable neuromodulation technology in patients with post-acute COVID-19 syndrome (PACS), commonly called Long COVID. The presentation was made at the National Science Foundation (NSF) funded Center to Stream Healthcare In Place (C2SHIP) annual meeting in Washington DC. The trial […]
Building the biomedical technology of the future

The Biomedical Engineering program at University of North Dakota has been accepted into a multi-university research group that is working to develop healthcare technologies for in-place care, and has received funding from the National Science Foundation to advance those efforts. Read more
Silverberry Genomix Joins C2SHIP, Announces Launch of Silverberry Learning Health System Platform.

Silverberry Genomix, a pioneer in personalized health services, today announced its partnership with the Center for Stream Healthcare in Place (C2SHIP), an initiative funded by the National Science Foundation (NSF). To mark this significant collaboration, Silverberry is also launching its innovative Learning Health System Platform, designed to advance personalized care and health outcomes across the […]
Dr. David G. Armstrong’s new achievements in research, practice, and leadership

1. The 2023 Association for Clinical and Translational Science (ACTS) Distinguished Investigator: Translation from Proof of Concept to Widespread Clinical Practice Award, American Association of Medical Colleges (AAMC), Washington, DC, April 2023 2. First Prize, Research, “Brooks BM, Brooks B, Tower DE, Simon J, Tran TT, Armstrong DG, Shih JD. “The Diabetic Foot-Pain-Depression Cycle: A Retrospective […]
Dr. Bijan Najafi inducted into the 2023 class of the AIMBE college of fellows

The American Institute for Medical and Biological Engineering (AIMBE) has announced the induction of Bijan Najafi, Ph.D., M.Sc., Professor of Surgery at Baylor College of Medicine to its College of Fellows. About AIMBE AIMBE is the authoritative voice and advocate for the value of medical and biological engineering to society. AIMBE’s mission is to recognize […]
Rockley just released a white paper on its cuffless, non-invasive, laser based blood pressure solution.

Based on its innovative laser-based technology, Rockley’s powerful technique for monitoring blood pressure does not rely on subject demographics, unlike many current cuffless blood pressure devices. The current standard of blood pressure measurement may not provide the full picture of an individual’s health because it is measured only periodically, usually at a medical appointment. Even […]
MIZZOU Becomes part of Center to Stream Healthcare in Place, an NSF consortium

Mizzou has become the fifth university to join the Center to Stream Healthcare in Place (C2SHIP), a National Science Foundation (NSF) consortium focused on helping patients monitor and manage their health at home. Read more at Mizzou
NeuroMetrix Reports that Quell® Wearable Neuromodulator to be Evaluated in Post-Acute COVID-19 Syndrome

NeuroMetrix, Inc. announced that its Quell wearable neuromodulation technology will be evaluated for treatment of a fibromyalgia-like syndrome in individuals with post-acute COVID-19 syndrome (PACS, or “long COVID”). Read more at NeuroMetrix